ILTAR, U. Et Al. 2021. Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy. LEUKEMIA & LYMPHOMA , vol.62, no.5 , 1098-1106.

ILTAR, U., SÖZEL, H., Sozel, Y. K., ATAŞ, Ü., YÜCEL, O. K., SALİM, O., ... AYDIN, F.(2021). Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy. LEUKEMIA & LYMPHOMA , vol.62, no.5, 1098-1106.

ILTAR, UTKU Et Al. "Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy," LEUKEMIA & LYMPHOMA , vol.62, no.5, 1098-1106, 2021

ILTAR, UTKU Et Al. "Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy." LEUKEMIA & LYMPHOMA , vol.62, no.5, pp.1098-1106, 2021

ILTAR, U. Et Al. (2021) . "Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy." LEUKEMIA & LYMPHOMA , vol.62, no.5, pp.1098-1106.

@article{article, author={UTKU ILTAR Et Al. }, title={Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy}, journal={LEUKEMIA & LYMPHOMA}, year=2021, pages={1098-1106} }